This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,419.18 firm fixed-price delivery order is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 mL, a medication used to treat type 2 diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order, with a completion date of December 24, 2024, is an example of AmerisourceBergen's role in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to federal agencies and military healthcare facilities.
Generated 3/24/25, 9:47 AM